Published in Transplantation on February 15, 1998
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med (2004) 1.43
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol (2015) 0.90
Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk. Gastroenterol Rep (Oxf) (2014) 0.87
The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience. Can J Gastroenterol (2010) 0.87
Clinical management of inflammatory bowel disease in the organ recipient. World J Gastroenterol (2014) 0.86
Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II. Dig Dis Sci (2008) 0.84
The role of tacrolimus in inflammatory bowel disease: a systematic review. Dig Dis Sci (2006) 0.81
Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis. Case Rep Gastroenterol (2009) 0.81
Crohn's disease and infections: a complex relationship. MedGenMed (2004) 0.80
The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease. J Gastroenterol (2008) 0.78
The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.77
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. PLoS One (2015) 0.76
Incidence and management of colorectal cancer in liver transplant recipients. Clin Colorectal Cancer (2008) 0.76
Genetics of primary sclerosing cholangitis and pathophysiological implications. Nat Rev Gastroenterol Hepatol (2017) 0.75
Inflammatory bowel disease after allogeneic stem cell transplantation. Bone Marrow Transplant (2015) 0.75
A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation. Gastroenterol Hepatol (N Y) (2014) 0.75
Collagenous colitis presenting after orthotopic liver transplantation for alpha-1-antitrypsin deficiency. Dig Dis Sci (2006) 0.75
Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature. Int J Colorectal Dis (2014) 0.75
Performance of four computer-based diagnostic systems. N Engl J Med (1994) 9.40
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med (1995) 5.98
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science (1992) 5.36
Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA (1995) 3.60
Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg (1991) 3.32
Transplantation of liver grafts from living donors into adults--too much, too soon. N Engl J Med (2001) 2.61
Ethics of liver transplantation with living donors. N Engl J Med (1989) 2.47
Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg (1990) 2.37
Attitudes of minority patients with end-stage renal disease regarding ABO-incompatible list-paired exchanges. Am J Transplant (2006) 2.33
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Aliment Pharmacol Ther (2013) 2.15
Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease. Am J Gastroenterol (1994) 1.99
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant (2013) 1.99
Liver disease associated with early syphilis. N Engl J Med (1971) 1.95
A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol (1998) 1.91
Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr (1998) 1.84
Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology (1989) 1.84
Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation (1995) 1.82
Equal Opportunity Supplemented by Fair Innings: equity and efficiency in allocating deceased donor kidneys. Am J Transplant (2012) 1.73
Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg (2000) 1.73
Acetylcholinesterase, I. Large-scale purification, homogeneity, and amino Acid analysis. Proc Natl Acad Sci U S A (1967) 1.72
Massive intra-hepatic and extra-hepatic bile cast formation after cholecystectomy. Gastrointest Endosc (1993) 1.70
The ethical assessment of innovative therapies: liver transplantation using living donors. Theor Med (1990) 1.67
Ethics of a paired-kidney-exchange program. N Engl J Med (1997) 1.66
Liver transplantation with reduced-size donor organs. Transplantation (1988) 1.66
A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am J Transplant (2006) 1.65
Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg (1990) 1.64
Is there any justification for the routine histological examination of straightforward cholecystectomy specimens? Ann R Coll Surg Engl (2007) 1.64
Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation (1997) 1.63
Review article: drug hepatotoxicity. Aliment Pharmacol Ther (2007) 1.60
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant (2014) 1.57
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol (1997) 1.55
Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant (2011) 1.54
Liver transplantation in children. Ann Surg (1991) 1.51
Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg (1990) 1.45
Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg (1988) 1.44
Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation (1999) 1.43
The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr (2001) 1.42
Susceptibility of prosthetic biomaterials to infection. Surg Endosc (2005) 1.41
Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation (1994) 1.39
Transplanting the highly sensitized patient: The emory algorithm. Am J Transplant (2006) 1.38
Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis (1998) 1.35
Liver transplantation in the management of fulminant hepatic failure. Gastroenterology (1989) 1.35
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet (1993) 1.28
Portal vein thrombosis and stenosis in pediatric liver transplantation. Transplantation (1996) 1.27
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol Psychiatry (2012) 1.27
Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg (1992) 1.23
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype. Am J Gastroenterol (2000) 1.21
The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation (1990) 1.21
Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun (2005) 1.21
Biliary complications in pediatric liver transplantation. A comparison of reduced-size and whole grafts. Transplantation (1992) 1.20
Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol (1999) 1.20
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20
Surgical management of benign tumors of the liver. Int J Gastrointest Cancer (2001) 1.19
Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant (2011) 1.18
The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers. Clin Pharmacol Ther (1982) 1.18
Miles to go…. Am J Transplant (2011) 1.17
A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation (1994) 1.16
Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med (1984) 1.14
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation (1996) 1.14
Choledochal cyst followed by carcinoma of the hepatic duct. South Med J (1967) 1.13
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol (2001) 1.13
Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg (1989) 1.12
One thousand liver transplants. The lessons learned. Ann Surg (1994) 1.12
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11
Is any method of vascular control superior in hepatic resection of metastatic cancers? Longmire clamping, pringle maneuver, and total vascular isolation. Arch Surg (2001) 1.11
Small-bowel length and the dose of cyclosporine in children after liver transplantation. N Engl J Med (1990) 1.10
Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med (1979) 1.10
Allograft rejection in pediatric recipients of living related liver transplants. Hepatology (1996) 1.10
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med (1995) 1.09
Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol (1996) 1.08
Complications in 100 living-liver donors. Ann Surg (1998) 1.07
Contraindications to lumbar puncture as defined by computed cranial tomography. J Neurol Neurosurg Psychiatry (1987) 1.07
Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver. Surg Gynecol Obstet (1990) 1.06
Acetylcholinesterase. II. Crystallization, absorption spectra, isoionic point. Proc Natl Acad Sci U S A (1968) 1.06
When the living and the deceased cannot agree on organ donation: a survey of US organ procurement organizations (OPOs). Am J Transplant (2014) 1.05
Hepatic artery reconstruction during liver transplantation. Transplantation (1989) 1.05
Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology (1980) 1.05
CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival. Cancer Res (1982) 1.03
Polyarteritis associated with Australia antigen-positive hepatitis. Gastroenterology (1972) 1.03
Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. Transplantation (1999) 1.02
Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2010) 1.02
Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation. Am J Transplant (2006) 1.01
Hepatic resection: effective treatment for primary and secondary tumors. Surgery (2000) 1.01
Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients. Ann Surg (2000) 1.01
Successful hepatic transplantation in congenital absence of recipient portal vein. Surgery (1990) 1.00
Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis (1991) 0.99
Effects of nutritional counseling on lipoprotein levels in a pediatric lipid clinic. Am J Dis Child (1993) 0.99
Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol Med (2012) 0.99
Jejunal diverticulosis with perforation as a complication of Fabry's disease. Gastroenterology (1984) 0.98
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody. J Immunol (1992) 0.98